Navigation Links
Get the latest on premier science in medical oncology
Date:7/30/2008

h ESMO Patient Seminar where patients will have the chance to meet oncologists and hear about the conditions of cancer treatment in Europe, comparing conditions in Eastern and Western countries; discuss and confront doctors about the consequences of cancer therapy, learn the approaches to long-term survivorship and the future perspective of cancer treatments

Numerous Educational Sessions to present state-of-the-art oncology.

The fifth batch of ESMO Designated Centers of Integrated Oncology and Palliative Care will be announced as centers of excellence for patient care in Europe.

A session on ESMO Clinical Recommendations will update current ESMO Guidelines on clinical practice for various tumor types.

Oncology Highlights of the most important advances in cancer treatment in 2008.

And Her Majesty Queen Silvia of Sweden accepted to be the Patron of the 33rd ESMO Congress and will give the welcome address during the Opening Ceremony

Meeting venue

The 33rd ESMO Congress will take place at the Stockholm International Fairs in lvsj, (Mssvgen 1, SE-12580 Stockholm-lvsj), located a short train journey from Stockholm Central Station.

Scheduled Press Conferences

Press Breakfast
Saturday, 13 September 2008, 9:30-10:30, ESMO Press Room

Press Conference #1
Saturday, 13 September 2008, 12:45 13:45, Press Conference Room

Press Conference #2
Sunday, 14 September 2008, 12:30 13:30, Press Conference Room

Press Conference #3
Monday, 15 September 2008, 12:30 13:30, Press Conference Room

The full Press Program will be available in the second half of August after the approval of the late-breaking abstracts.

Services for media representatives

A fully equipped press room will be in operation at the conference with Internet access and telephone lines for registered reporters. In addition to attending Press Conferences you will also have
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...- The Providence Service,Corporation (Nasdaq: P...mpany,s,Chief Operating Officer, has been appoint...is, appointment fills the vacancy left by the Apri...rns the board to six members. Mr.,Norris will no.... Norris, age 41, has been with Providence since i...
(Date:11/21/2008)...ennox-Gastaut syndrome , , FRIDAY, Nov. ...ufinamide) has been approved as a supplementary tr...x-Gastaut syndrome, the U.S. Food and Drug Adminis...sed on results of a four-month clinical trial that...nts who took a placebo, those who took the drug ha...
(Date:11/21/2008)...re/ -- New research at West Virginia University ... product aimed at young adults is catching on. And...l Snus - touted as a socially acceptable way to sa...s of nicotine. , , "Camel Snus contains mor...ruce Adkins of the state Division of Tobacco Preve...
(Date:11/21/2008)... -- U.S. News & World Report and the National ...Choice(R) HealthPlan of South Carolina in the top ...d in U.S. News & World Report,s issue this wee...he nation,s best health plans based on clinical qu...scores. NCQA and U.S. News & World Report rank...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
...u.s., mothers who breastfed their babies in public... act was made to prove that breastfeeding was an a...h mother and child. The U.S. Healthy People 2010 ...n of mothers who choose to breastfeed their babies...
... National Institutes of Health (NIH) and the Cente...oday that more than one-third of adults having dia...abetes in adults aged 20 and older has increased f...period between 1988 to 1994 and 1999 to 2002. How...
...ervations on one side and on the other side increa... does not suffer is the UPA Government’s please-a...eft supporters announced that 27 per cent of the s...ns would be available to Other Backward Classes (O...
...une diseases, named Juvenile rheumatoid arthritis ...which inversely affect health-related quality of l...gests patient prognosis in adults – study finds. B...d. Arthritis Care & Research journal published a...
Other Medicine News:Health News:Breastfeeding Mothers Arrested For Public Indecency 2Health News:Undetected Cases Of Diabetes Boom In The US 2Health News:Undetected Cases Of Diabetes Boom In The US 3Health News:Undetected Cases Of Diabetes Boom In The US 4Health News:The Government’s Balancing Act on Reservatio 2Health News:The Government’s Balancing Act on Reservatio 3Health News:Socioeconomic Status Plays A Role In Juvenile Rheumatoid Arthritis 2
(Date:11/20/2008)...wire/ -- Epeius Biotechnologies,announced today t... in,chemotherapy-resistant metastatic soft tissue...nt P. Chawla, principal investigator, at the CTOS ...r 13-15, 2008. Patients received,repeated infusio...nalysis of,safety and efficacy data showed no maj...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...linical data from a prospective,registry presente...ws DVT,treatment with the Trellis(R) Peripheral I... Clara, CA) successfully breaks up the blood clot ...is technique, called isolated pharmacomechanical t... safely than current catheter-directed thrombolysi...
(Date:11/19/2008)...tatistical significance , , ISELIN, N.J., N...ion (Nasdaq: PARS ) today announced results from...ulsion (NE) drug delivery technology formulated wi...lti-center, randomized, double-blinded, placebo-co...f the Company,s 3% Diclofenac Diethanolamine NanoE...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Off Hours Heart Patients Less Likely to Get Angioplasty 17343 1Off Hours Heart Patients Less Likely to Get Angioplasty 17343 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 1Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 2Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 3Analysis of RNA role in spreading disease advances study of damaging plant infections 2981 4Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 1Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results 4742 2Crop management strategies key to a healthy Gulf planet 2980 1Crop management strategies key to a healthy Gulf planet 2980 2Crop management strategies key to a healthy Gulf planet 2980 3
...ong ADHD Patients Nearly Triple That,of General Po..., INDIANAPOLIS, May 23, 2007 /PRNewswire-FirstCall...ttera(R) (atomoxetine HCl),improved symptoms of At...patients with comorbid alcohol abuse disorder, sug... with Strattera in,patients with both disorders. R...
...ty Demonstrated Among Patients with,Active Disease... --,ChemoCentryx, Inc., a clinical-stage biopharma...g and commercializing,orally-administered therapeu...ata today from the company,s Phase 2 clinical tria...-inflammatory agent,that targets the chemokine rec...
Other Medicine Technology:Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 2ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 3ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 4ChemoCentryx Presents Positive Phase 2 Clinical Data for,Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007,Conference 5
Ideal for chest procedures.
Male Compression Vests
Female Compression VEST w/sleeves
Male Support Brief
Medicine Products: